News | 02.10.20
Study Demonstrates Relationship Between Hospital SAVR Volume and TAVR Outcomes
February 10, 2020—Sameer A. Hirji, MD, et al conducted a study that examined whether hospital surgical aortic valve replacement (SAVR) volume was associated with corresponding transcatheter aortic valve replacement (TAVR) outcomes. The investigators published the findings from the study in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions (2020;13:335–343).
News | 02.05.20
JenaValve Technology Closes $50 Million Financing Equity Round
February 5, 2020—JenaValve Technology, Inc. announced that it has raised $50 million in equity financing to support an ongoing clinical program for the company’s JenaValve pericardial transcatheter aortic valve replacement (TAVR) system for the treatment of aortic valve disease.
News | 01.30.20
Financing Completed to Support Regulatory and Commercialization Progress of Emboline’s Embolic Protection Catheter
January 30, 2020—Emboline, Inc., developer of embolic protection technology for transcatheter aortic valve replacement (TAVR), announced the closing of a $5 million bridge round of financing from a number of existing and new investors.
News | 01.30.20
Abbott’s Tendyne TMVI System Receives CE Mark Approval
January 30, 2020—Abbott announced that its Tendyne transcatheter mitral valve implantation (TMVI) system received European CE Mark approval for the treatment of significant mitral regurgitation (MR) in patients requiring a heart valve replacement for MR patients who are not candidates for open heart surgery or transcatheter mitral valve repair.
News | 01.15.20
Enrollment Completed in SafePass 2 Study of Emboline's Embolic Protection Catheter for TAVR
January 15, 2020—Emboline, Inc. announced the completion of enrollment in the company’s SafePass 2 clinical study of the Emboliner embolic protection catheter for use with transcatheter aortic valve replacement (TAVR).
News | 01.13.20
FDA Approves REPAIR MR Trial for Abbott's MitraClip in Patients at Moderate Surgical Risk
January 13, 2020—Abbott announced that the FDA has approved a clinical trial that will compare the effectiveness of the company’s transcatheter MitraClip device to mitral valve surgical repair in patients with primary mitral regurgitation (MR) who are eligible for open heart surgery.
News | 01.09.20
JenaValve Pericardial TAVR System Receives FDA Breakthrough Device Designation
January 9, 2020—JenaValve Technology, Inc. announced that it has received FDA Breakthrough Device designation for its JenaValve pericardial transcatheter aortic valve replacement (TAVR) system for the treatment of aortic valve disease.
News | 01.06.20
Multisociety Expert Systems of Care Document Addresses Transcatheter Mitral Valve Intervention
January 6, 2020—A report on transcatheter mitral valve intervention (TMVI) issued by the American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC), Society for Cardiovascular Angiography and Interventions (SCAI), and Society of Thoracic Surgeons (STS) was recently accepted for publication.
News | 12.16.19
Outcomes Reported From Compassionate Use Experience With Edwards' Pascal Transcatheter Valve Repair System for Severe Tricuspid Regurgitation
December 16, 2019—Findings from an investigation of the feasibility and safety of the Pascal transcatheter valve repair system (Edwards Lifesciences) for severe tricuspid regurgitation (TR) in a multicenter, observational, first-in-human experience were published by Neil P. Fam, MD, et al in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions (2019;12:2488–2495).
News | 12.03.19
Study Compares Outcomes of Edwards' Sapien 3 Versus Previous-Generation Sapien XT TAVR Devices
December 3, 2019—Gerhard Schymik, MD, et al published a study comparing two generations of Sapien transfemoral (TF) balloon-expandable transcatheter aortic valve replacement (TAVR) devices (Edwards Lifesciences).
News | 11.27.19
Study Evaluates Association Between Diastolic Dysfunction and Health Status Outcomes in Patients Undergoing TAVR
November 27, 2019—Findings from a study that aimed to assess the association of baseline left ventricular diastolic dysfunction (LVDD) with health status outcomes of patients undergoing transcatheter aortic valve replacement (TAVR) were published by Ali O. Malik, MD, et al in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions.
News | 11.20.19
LivaNova Ends Caisson TMVR Program, Will Restructure Its Heart Valve Business
November 20, 2019—LivaNova PLC announced that it is ending its Caisson transcatheter mitral valve replacement (TMVR) program and will undertake a restructuring of its heart valve business to improve profitability and ensure business continuity.
News | 11.19.19
Neovasc's Tiara System Early Data Presented in a Conference Tutorial Session
November 19, 2019—Neovasc, Inc. announced its Tiara transfemoral/transseptal (TF/TS) system was featured in a tutorial session focusing on the early clinical outcomes for patients undergoing transcatheter mitral valve replacement at the PCR London Valves 2019 meeting, held November 17–19 in London, England.
News | 11.16.19
AHA and the Mitral Foundation Launch a Joint Recognition Program for Mitral Valve Surgery
November 16, 2019—The Mitral Foundation and the American Heart Association (AHA) announced a new collaborative initiative during the AHA scientific sessions 2019, held November 16–18 in Philadelphia, Pennsylvania.
News | 11.11.19
MARVEL 2 Evaluates Algorithms for Use With Medtronic's Micra Transcatheter Pacemaker in Treatment of Atrioventricular Block
November 11, 2019—Medtronic announced results from the MARVEL 2 trial were published online by Clemens Steinwender, MD, et al in Journal of the American College of Cardiology (JACC): Clinical Electrophysiology.
News | 11.06.19
Edwards' Sapien 3 TAVR System Approved in Europe for Low-Risk Patients
November 6, 2019—Edwards Lifesciences announced that it has received CE Mark approval to expand use of the Sapien 3 transcatheter heart valve for the treatment of patients with aortic stenosis who are at low risk for open heart surgery.
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available interventional cardiology devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available interventional cardiology devices in Europe.